NIFTY
-157.50  -1.56%
 9964.40
S&P BSE SENSEX
-447.60  -1.38%
 31922.44
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 22-Sep-2017
NSE
-5.8    -1.12%
Rs. 513.85
 
Days Low
Rs. 508
Days High
Rs. 528.7

Open Rs. 518
 
52 week Low
Rs. 433.15
52 week High
Rs.792.2
 
 
Bid :                 0.00 (0)
Offer :        512.50 (48)
BSE
Rs.513.30
-6.25    -1.2%
on 22-Sep-2017
BSE
-6.25    -1.2%
Rs. 513.30
 
Days Low
Rs. 508.7
Days High
Rs. 528.5

Open Rs. 518.95
 
52 week Low
Rs. 432.7
52 week High
Rs.790.75
 
 
Bid :                 0.00 (0)
Offer :        512.50 (48)
NSE
Rs.513.85
-5.8    -1.12%
 
 
Last Price (Rs.)  513.30 Value  382008477.00
Net Change (Rs.)  -6.25 Best Buy  0.00
Volume  732687 Best Sell  512.50
Prev.Close (Rs.)  519.55 Best Quantity  0
Open (Rs.)  518.00 Sell Quantity  48
High (Rs.)  528.70 52-Week High (Rs.)  792.20
Low (Rs.)  508.00 52-Week Low (Rs.)  433.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1231564.27
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Currents Investments400.10 735.60 939.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cadila Healthcare 489.15 500764 65.54 75.67 0.65
Piramal Enterprises 2746.35 473919 838.20 61.01 0.76
Cipla 583.80 469775 161.56 48.17 0.34
Lupin 1013.55 457919 331.14 14.57 0.74
Aurobindo Pharma 724.05 424208 149.24 24.86 0.35
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2017Mar 2017Dec 2016
Net Sales18025.2020171.7019352.60
Operating Profit-1470.201957.30578.10
PBDT-11809.601948.40-563.00
Net Profit-12909.90946.30-1626.60
More> 
 
Company News
9/22/2017 12:00:00 AM
Sun Pharma trades higher on the bourses
9/20/2017 12:00:00 AM
Sun Pharma’s arm receives USFDA approval for new label for Odomzo
9/11/2017 12:00:00 AM
Sun Pharma gets NCLT’s approval for Scheme of Arrangement
More>
 
Ratios
   Earnings Per Share (Rs)-0.15 
   Book NAV/Share(Rs)86.98 
   PAT Margin (%)-0.45 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.51 
   EV/Core EBITDA(x)280.28 
   M Cap / Sales21.44 
   Net Sales Growth(%)-0.46 
   PAT Growth(%)96.79 
   Total Debt/Equity(x)0.29 
   Current Ratio(x)0.58 
   Quick Ratio(x)0.37 
   Total Debt/Mcap(x)0.04 
More>